Viveve Medical, Inc.

Equities

VIVE

US92852W5013

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 01:08:38 2024-05-24 pm EDT			5-day change	1st Jan Change
0.0003 ^USD	0.00%		0.00%	+50.00%

2023	InMode Ltd. acquired Intellectual Property Assets of Viveve Medical Inc.	CI
2023	Viveve Medical, Inc.(OTCPK:VIVE) dropped from S&P TMI Index	CI

Viveve Medical Names Grant Stevens as Chairman of Aesthetic Advisory Board

January 31, 2017 at 08:28 am EST

Viveve Medical, Inc. announced that W. Grant Stevens, MD, FACS, has been named as chairman of the company's Aesthetic Advisory Board. Dr. Stevens is the founder and medical director of Marina Plastic Surgery and The Institute, a medical spa in Marina Del Rey, California, as well as medical director for Body by OrangeTwist aesthetic centers.

Latest news about Viveve Medical, Inc.

InMode Ltd. acquired Intellectual Property Assets of Viveve Medical Inc.	23-07-24	CI
Viveve Medical, Inc.(OTCPK:VIVE) dropped from S&P TMI Index	23-01-23	CI
Viveve Medical, Inc.(OTCPK:VIVE) dropped from NASDAQ Composite Index	23-01-18	CI
Sector Update: Health Care Stocks Finishing Near Intra-Day Lows	23-01-17	MT
Sector Update: Health Care Stocks Sputtering in Tuesday Trading	23-01-17	MT
Top Midday Decliners	23-01-17	MT
Sector Update: Health Care	23-01-17	MT
Sector Update: Health Care Stocks Flat to Lower Premarket Tuesday	23-01-17	MT
Sector Update: Health Care	23-01-17	MT
Investors Digest More Big Bank Earnings, Weighing on US Equity Futures	23-01-17	MT
Weak China GDP Data Weigh on Exchange-Traded Funds, Equity Futures Premarket Tuesday	23-01-17	MT
Top Premarket Decliners	23-01-17	MT
Viveve Medical Fails to Meet Primary Endpoint in Stress Urinary Incontinence Study; Unveils Cut in Workforce; Expects Delisting From Nasdaq	23-01-17	MT
Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence	23-01-17	CI
Viveve Medical to Seek Strategic Alternatives	23-01-16	CI
Viveve Medical, Inc. Announces Completion of Pivotal US Pursuit Trial for Female Stress Urinary Incontinence	22-12-15	CI
Transcript : Viveve Medical, Inc., Q3 2022 Earnings Call, Nov 10, 2022	22-11-10
Viveve Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
Earnings Flash (VIVE) VIVEVE MEDICAL Posts Q3 Revenue $1.7M	22-11-10	MT
Viveve Medical, Inc. announced that it has received $0.014675 million in funding	22-10-26	CI
Viveve Medical, Inc. announced that it expects to receive $0.014675 million in funding	22-10-13	CI
Viveve Medical, Inc. Announces Notice of Allowance for Second U.S. Method Patent for Treating Female Stress Urinary Incontinence	22-10-04	CI
Viveve Medical, Inc. Launches Rebranding Initiative to Reflect Focus on Treatment of Female Stress Urinary Incontinence in Anticipation of U.S. Pivotal Pursuit Trial Readout	22-09-27	CI
Transcript : Viveve Medical, Inc., Q2 2022 Earnings Call, Aug 11, 2022	22-08-11
Viveve Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI

Chart Viveve Medical, Inc.

Duration

Period

More charts

Company Profile

Viveve Medical, Inc. designs, develops, manufactures and markets a platform medical technology, Cryogen-cooled Monopolar RadioFrequency (CMRF). The Companyâs CMRF technology is delivered through a radiofrequency generator, handpiece and treatment tip, which collectively, is referred to as the Viveve System. The Viveve System is marketed for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence (SUI). In the United States, the Viveve System is indicated for use in general surgical procedures for electrocoagulation and hemostasis. The Viveve System is cleared for marketing in approximately 48 countries throughout the world, including North America, Asia Pacific, Europe, the Middle East and Latin America countries. The Companyâs wholly owned subsidiaries include Viveve, Inc. and Viveve BV.

Sector

Advanced Medical Equipment & Technology

More about the company

	1st Jan change	Capi.
VIVEVE MEDICAL, INC.	+50.00%	3.22K
THERMO FISHER SCIENTIFIC	+10.03%	223B
DANAHER CORPORATION	+13.59%	195B
INTUITIVE SURGICAL, INC.	+20.01%	144B
BOSTON SCIENTIFIC CORPORATION	+30.83%	111B
SIEMENS HEALTHINEERS AG	+2.05%	65.01B
EDWARDS LIFESCIENCES CORPORATION	+15.38%	53.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+3.96%	50.45B
AGILENT TECHNOLOGIES, INC.	+8.37%	44.15B
GE HEALTHCARE TECHNOLOGIES INC.	+3.27%	36.45B

Other Advanced Medical Equipment & Technology

Viveve Medical, Inc.

Equities

VIVE

US92852W5013

Advanced Medical Equipment & Technology

Viveve Medical Names Grant Stevens as Chairman of Aesthetic Advisory Board

Latest news about Viveve Medical, Inc.

Chart Viveve Medical, Inc.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology